Relief Therapeutics Holding AG (RLFTF)

[r_deckard]

Thanks for your upddate!

Can you also confirm the following from Javitts speech:

(Credit to User Bass from YF)
Explained history of VIP and results from the 19/21 patients open label study paper that was published pre-print.
- 19 of 21 patients open label compared to 30 patients in control.
19 survived of 21
8 out of 30 survived in the control
3 fold improvement with those that had aviptadil
early good indicators with inhalant
EUA filed on 9/17, results for ph3 IV expected in a month

The last one (EUA filed) would be big news, if confirmed!